Apple Inc.
AAPL Coverage
Page 200Barron’s: Apple is worth $194
From Tae Kim's Why There’s Still Plenty of Value in Apple’s Core in this week's magazine ($).
Here’s what Trump said about Apple’s warning (video)
Count the Pinocchios.
Morgan Stanley sees iPhone sales falling 17% in ’19
From a note to clients by analyst Katy Huberty that landed on my desktop Friday.
Jim Cramer blames the commies (video)
"I think they're circling wagons around their own companies" From Cramer sees an Apple bottom of $120 per share: I have felt all along something that no…
Watch the Apple sell-side analysts dive for cover
Did they warn their clients that Apple was about to plunge?
Apple falls to fourth place
Not that it matters (unless you have to sell).
WSJ: How Huawei cleaned Apple’s clock (video)
From Jay Greene and Yoko Kubota's post-mortem in Friday's Wall Street Journal ($).
4 Large-Cap Tech Stocks to Buy for 2019 With Zero Apple Exposure
Investors with a long-term view, those that can look past the recent volatility, can own these four stocks at very good entry points, given the recent selling. Plus with limited or no…
The List of Best-Run Companies Includes a Number That Aren’t
The Wall Street Journal list of the best-run U.S. companies of 2018 has several that are not well run at all, including these five.
Apple, Bristol-Myers Plummet into Thursday’s 52-Week Low Club
Apple, Bristol-Myers, Delta Air Lines, and United Continental all posted new 52-week lows on Thursday.
Apple’s fail: And now a word from the Twittersphere
There's wisdom in the crowd, but you have to know where to look.
Wall Street Needs to Get Real About Banking and Finance Expectations for 2019
Throughout history, it has been hard for the stock market as a whole to rise if the major banks and financials perform poorly. While this may sound gloomy, it does not assure…
Top Analyst Upgrades and Downgrades: AbbVie, Agilent, Albermarle, Apple, Boeing, Cheniere, First Solar, HCA, LabCorp, Lumber Liquidators, Teva and More
The top analyst upgrades, downgrades and initiations seen on Thursday included AbbVie, Agilent Technologies, Albermarle, Apple, Boeing, Cheniere Energy, First Solar, HCA, LabCorp, Lumber Liquidators and Teva Pharmaceutical.
Apple’s revised guidance: What the analysts are saying
Price target cuts across the board, ratings mostly unchanged.